Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single‐center, phase I, randomized, four‐way crossover study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single‐center, phase I, randomized, four‐way crossover study

Published:2013-11-16 Issue:1 Volume:54 Page:75-86
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Breitschaft Astrid¹,Hu Ke²,Darstein Christelle³,Ligueros‐Saylan Monica²,Jordaan Pierre⁴,Song Dongweon²,Hudson Michelle²,Shah Rashmi⁵

Affiliation:

1. Parexel International GmbHKlinikum WestendBerlinGermany

2. Novartis Pharmaceuticals CorporationEast HanoverNJUSA

3. Novartis Pharma AGBaselSwitzerland

4. Novartis Institutes for BioMedical ResearchBaselSwitzerland

5. Rashmi Shah Consultancy LtdGerrards CrossUK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.213

Reference34 articles.

1. Systemic Hypertension and Impaired Glucose Tolerance Are Independently Correlated to the Severity of the Acromegalic Cardiomyopathy

2. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients

3. Cardiovascular aspects in acromegaly: Effects of treatment

4. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study

5. High Prevalence of Prolonged QT Interval Duration in Male Patients with Cushing's Disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Cardiovascular Risk in Pituitary Disorders;Medicina;2024-07-30

2. Efficacy and Safety of Pegvisomant in the Treatment of Acromegaly;Archives of Medical Research;2023-12

3. Pharmacokinetics and Safety of Long-Acting Release Formulations of Pasireotide (SOM230) in a Male Population Who Are Hyperendemic Hepatitis B/C and Chronic Kidney Disease: An Open-Label, Phase I Study;European Journal of Drug Metabolism and Pharmacokinetics;2023-09-26

4. Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience;The Journal of Clinical Endocrinology & Metabolism;2023-06-26

5. Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs);Medicina;2022-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3